A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial

Autor: Brakenhoff, Timo B., Franks, Billy, Goodale, Brianna Mae, van de Wijgert, Janneke, Montes, Santiago, Veen, Duco, Fredslund, Eskild K., Rispens, Theo, Risch, Lorenz, Dowling, Ariel V., Folarin, Amos A., Bruijning, Patricia, Dobson, Richard, Heikamp, Tessa, Klaver, Paul, Cronin, Maureen, Grobbee, Diederick E., Denaxas, Spiros, Reitsma, Johannes B., Simon, Christian, Kuchta, Alison, Stolk, Pieter, Downward, George, van Lier, René, Kjellberg, Jakob, Risch, Martin, Grossmann, Kirsten, Conen, David, Aeschbacher, Stefanie

Publikováno v: Trials, 22(1):694. BioMed Central
Brakenhoff, Timo B; Franks, Billy; Goodale, Brianna Mae; van de Wijgert, Janneke; Montes, Santiago; Veen, Duco; Fredslund, Eskild K; Rispens, Theo; Risch, Lorenz; Dowling, Ariel V; Folarin, Amos A; Bruijning, Patricia; Dobson, Richard; Heikamp, Tessa; Klaver, Paul; Cronin, Maureen; Grobbee, Diederick E (2021). A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Trials, 22(1), p. 694. BioMed Central 10.1186/s13063-021-05643-5
Trials, Vol 22, Iss 1, Pp 1-5 (2021)
TRIALS
Trials, 22(1):412. BioMed Central
Trials

Objectives It is currently thought that most—but not all—individuals infected with SARS-CoV-2 develop symptoms, but that the infectious period starts on average two days before the first overt symptoms appear. It is estimated that pre- and asympt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3ba97a3c714686add1a848d2dcb4fcf
https://pure.amc.nl/en/publications/a-prospective-randomized-singleblinded-crossover-trial-to-investigate-the-effect-of-a-wearable-device-in-addition-to-a-daily-symptom-diary-for-the-remote-early-detection-of-sarscov2-infections-covidred(39bb8b72-6f34-4a62-a129-a1980ac00460).html

ANALYTICAL VALIDATION OF WITHINGS DIGITAL HEALTH TECHNOLOGIES FOR USE IN DECENTRALIZED CLINICAL TRIALS

Autor: Kaseman, Andrew, Imsirovic, Jasmin, Dowling, Ariel V., Godino, Job, Moran, Ryan

Publikováno v: In Cardiovascular Digital Health Journal December 2023 4(6):198-198

IMPLEMENTATION OF CONTINUOUS RESPIRATORY MONITORING DURING POST-ANESTHESIA RECOVERY IN A CLINICAL TRIAL

Autor: Imsirovic, Jasmin, Dowling, Ariel V., Kaseman, Andrew, Karas, Marta, Tolkoff, Max, Sullivan, Danielle, Piksa, Mateusz, Wu, Rebecca

Publikováno v: In Cardiovascular Digital Health Journal December 2023 4(6):199-200

Wearable Sensors in Huntington Disease: A Pilot Study.

Autor: Andrzejewski, Kelly L.¹, Dowling, Ariel V.², Stamler, David³, Felong, Timothy J.⁴, Harris, Denzil A.⁵, Wong, Cynthia³, Hang Cai², Reilmann, Ralf⁶, Little, Max A.^7,8, Gwin, Joseph T.², Biglan, Kevin M.^1,4, Dorsey, E. Ray^1,4 ray.dorsey@chet.rochester.edu

Publikováno v: Journal of Huntington's Disease. 2016, Vol. 5 Issue 2, p199-206. 8p.

Wearable sensors in Huntington disease:a pilot study

Autor: Andrzejewski, Kelly L., Dowling, Ariel V., Stamler, David, Felong, Timothy J., Harris, Denzil A., Wong, Cynthia, Cai, Hang, Reilmann, Ralf, Little, Max A., Gwin, Joseph T., Biglan, Kevin M., Dorsey, E. Ray

Background: The Unified Huntington’s Disease Rating Scale (UHDRS) is the principal means of assessing motor impairment in Huntington disease but is subjective and generally limited to in-clinic assessments. Objective: To evaluate the feasibility an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::464b6c2d9b46bb1725495f10181d9476
https://publications.aston.ac.uk/id/eprint/28234/1/wearables_HD_2016.pdf